Autocrine costimulation: Tumor-specific CD28-mediated costimulation of T cells by in situ production of a bifunctional B7–anti-CEA diabody fusion protein-Reference-Cited by-同舟云学术

Autocrine costimulation: Tumor-specific CD28-mediated costimulation of T cells by in situ production of a bifunctional B7–anti-CEA diabody fusion protein

Published:2002-03 Issue:3 Volume:9 Page:275-281
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Blanco Belén,Holliger Philipp,Álvarez-Vallina Luis

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/7700438.pdf

Reference25 articles.

1. Townsend A, Bodmer H . Antigen recognition by class I–restricted T lymphocytes Annu Rev Immunol 1989 7: 601–624

2. Jenkins MK . The ups and downs of T cell costimulation Immunity 1994 1: 443–446

3. Tan P, Anasetti C, Hansen JA, Melrose J, Brunraud M, Bradshow J, Ledbetter J, Linsley PS . Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1 J Exp Med 1993 177: 165–173

4. Mueller DL, Jenkins MK, Schwartz RH . Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy Annu Rev Immunol 1989 7: 445–480

5. Linsley PS, Ledbetter JA . The role of the CD28 receptor during T cell responses to antigen Annu Rev Immunol 1993 11: 191–212

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering Immune Cells for in vivo Secretion of Tumor-Specific T Cell-Redirecting Bispecific Antibodies;Frontiers in Immunology;2020-08-13

2. T Cell-Redirecting Strategies to ‘STAb’ Tumors: Beyond CARs and Bispecific Antibodies;Trends in Immunology;2019-03

3. Balanced secretion of anti-CEA × anti-CD3 diabody chains using the 2A self-cleaving peptide maximizes diabody assembly and tumor-specific cytotoxicity;Gene Therapy;2017-01-11

4. Efficient Inhibition of Human B-cell Lymphoma in SCID Mice by Synergistic Antitumor Effect of Human 4-1BB Ligand/Anti-CD20 Fusion Proteins and Anti-CD3/Anti-CD20 Diabodies;Journal of Immunotherapy;2010-06

5. Lymphocyte Display: A Novel Antibody Selection Platform Based on T Cell Activation;PLoS ONE;2009-09-24